Sales Increase by 18.2% to EUR239.1m in the First Quarter of 2008
Operating Result (Adjusted EBITDA) Improves by 20.4% to EUR43.0m Integration of the Acquisitions EDP and Allplas Progressing in Line With
Plan
DUSSELDORF, Germany, April 14 /PRNewswire-FirstCall/ --
- CEO Dr. Axel Herberg: "We Have Again Substantially Increased our Sales and Earnings, and Results are Fully in Line With our Forecasts."
Gerresheimer AG has started the financial year 2008 with an outstanding first quarter. Sales grew by 18.2% compared with the prior year period to EUR239.1m (2007: EUR202.3m). Excluding exchange-rate effects, sales actually rose by 21.8%. The operating result (Adjusted EBITDA) also improved again, increasing by 20.4% to EUR43.0m (prior year period: EUR35.7m). The Adjusted EBITDA margin therefore reached 18.0% in the first quarter (December 2007 - February 2008), which is seasonally the weakest quarter over the course of the year. The adjusted net income, which shows the operating strength of the company, almost quadrupled to EUR9.9m (prior year period: EUR2.6m). The net income improved by EUR6.5m to EUR2.5m (prior year period: EUR-4.0m). Overall, Gerresheimer profited primarily from the high level of demand in the pharma & life science segment, where the company achieves three quarters of its total sales.
"The first quarter was extremely successful for us. We improved our results in all divisions and are therefore well ahead of the overall market development. Gerresheimer is outstandingly well positioned and we are well on the way to achieving our ambitious targets for the current financial year," says Dr. Axel Herberg, CEO of Gerresheimer AG.
Successful development of all divisions
All the divisions contributed to the positive development of the Group.
In addition to the sustained high level of demand for Gerresheimer
products, this was attributable to the successful integra
'/>"/>
| SOURCE Gerresheimer AG Copyright©2008 PR Newswire. All rights reserved |